A DNA alkylating agent
Related Products
Pro-drug Form(s)
14163Temozolomide
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

MTIC

Item No. 18863

Technical Information
Formal Name
5-[2-(methylimino)hydrazinyl]-1H-imidazole-4-carboxamide
CAS Number
3413-72-7
Synonyms
  • NSC 407347
Molecular Formula
C5H8N6O
Formula Weight
Purity
≥98%
A crystalline solid
DMSO: slightlyMethanol: slightly (heated)
λmax
230, 315 nm
SMILES
NC(C1=C(/N=N/NC)NC=N1)=O
InChi Code
InChI=1S/C5H8N6O/c1-7-11-10-5-3(4(6)12)8-2-9-5/h2H,1H3,(H2,6,12)(H,7,10)(H,8,9)
InChi Key
MVBPAIHFZZKRGD-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    MTIC is a DNA alkylating agent, an active metabolite of dacarbazine (DTIC; Item No. 21877), and an active degradation product of temozolomide (Item No. 14163).1,2,3 MTIC is cytotoxic to L-cells and decreases thymidine and uridine uptake by 55 and 65%, respectively, when used at a concentration of 1 mM.2 It is also cytotoxic to TLX5 murine lymphoma cells in a concentration-dependent manner.3 In vivo, MTIC induces formation of mammary adenofibromas in rats when administered at a cumulative dose of 890 mg per animal over 14 weeks.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Nagasawa, H.T., Shirota, F.N., and Mizuno, N.S. The mechanism of alkylation of DNA by 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MIC), a metabolite of DIC (NSC-45388). Non-involvement of diazomethane. Chem. Biol. Interact. 8(6), 403-413 (1974).

    2. Beal, D.D., Skibba, J.L., Whitnable, K.K., et alEffects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells. Cancer Res. 36(8), 2827-2831 (1976).

    3. Tsang, L.L.H., Quarterman, C.P., Gescher, A., et alComparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide. Cancer Chemother. Pharmacol. 27(5), 342-346 (1991).

    4. Beal, D.D., Skibba, J.L., Croft, W.A., et alCarcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats. J. Natl. Cancer Inst. 54(4), 951-957 (1975).